Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.27 | 19.84 |
| PEG Ratio (TTM) | 4.16 | 3.20 |
| P/S Ratio (TTM) | 3.41 | 3.48 |
| P/B Ratio (TTM) | 1.78 | 9.56 |
| P/FCF Ratio (TTM) | -8.23 | -32.51 |
| Price to 5YR AVG Earnings Ratio | 25.66 | 12.49 |
| Price to 5YR AVG FCF Ratio | -23.97 | -79.87 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.64% | 2.78% |
| ROE (TTM) | 5.98% | 10.36% |
| Net Profit Margin (TTM) | 11.64% | 14.79% |
| ROIC 5YR AVG | 3.52% | 5.29% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 40.23% | 30.67% | 22.32% |
| Revenue | -1.61% | 2.68% | 2.14% |
| Net Income | 35.77% | 35.61% | 27.34% |
| Cash Flow | 94.52% | -4.43% | 11.20% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.93 | 0.85 |
| Quick Ratio (TTM) | 0.78 | 0.66 |
| D/E Ratio (TTM) | 1.53 | 7.27 |
| Interest Coverage (TTM) | 2.23 | 4.41 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.70 | 1.10 |
| LTL to 5YR AVG FCF | -16.45 | -36.37 |
| Shares Outstanding Growth 5YR AVG | 4.45% | 11.30% |